AAAAAA

   
Results: 1-3 |
Results: 3
A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage
Authors: Hohenstein, P Kielman, MF Breukel, C Bennett, LM Wiseman, R Krimpenfort, P Cornelisse, G van Ommen, GJ Devilee, P Fodde, R
Citation: P. Hohenstein et al., A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage, ONCOGENE, 20(20), 2001, pp. 2544-2550
Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity
Authors: Smits, R Hofland, N Edelmann, W Geugien, M Jagmohan-Changur, S Albuquerque, C Breukel, C Kucherlapati, R Kielman, MF Fodde, R
Citation: R. Smits et al., Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity, GENE CHROM, 29(3), 2000, pp. 229-239
Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development
Authors: Smits, R Kielman, MF Breukel, C Zurcher, C Neufeld, K Jagmohan-Changur, S Hofland, N van Dijk, J White, R Edelmann, W Kucherlapati, R Khan, PM Fodde, R
Citation: R. Smits et al., Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development, GENE DEV, 13(10), 1999, pp. 1309-1321
Risultati: 1-3 |